Longevity & Mitochondrial Peptides: A Researcher's Guide. Longevity and mitochondrial peptides represent one of the most active frontiers in ageing biology and metabolic research. Compounds that target mitochondrial function, cellular energy metabolism, and age-related decline have attracted significant scientific interest over the past decade — and a small group of research peptides sits at the centre of this field. This guide covers the key longevity and mitochondrial peptides available for laboratory research in the UK, what makes each one distinct, and how they relate to one another.
What Are Longevity and Mitochondrial Peptides?
Longevity peptides are compounds studied for their interactions with biological pathways associated with ageing, cellular energy production, and metabolic regulation. Mitochondrial peptides specifically target the mitochondria — the cell’s primary energy-producing organelles — and are of particular interest in research exploring how mitochondrial dysfunction contributes to age-related disease. Like all research peptides, they are supplied strictly for in-vitro and laboratory investigation only.
NAD+: Longevity Coenzyme and Central Metabolic Research Tool
NAD+ (Nicotinamide Adenine Dinucleotide) is one of the most studied molecules in ageing biology and metabolic research. Found in every living cell, it plays a central role in cellular energy metabolism, DNA repair, and the regulation of circadian rhythms. NAD+ levels decline significantly with age, making it a focal point in longevity peptide research.
Key research areas include:
- Cellular energy metabolism and mitochondrial function
- Sirtuin (SIRT1–7) pathway activation and longevity research
- DNA damage repair mechanisms (PARP pathway)
- Ageing biology and age-related metabolic decline
- Metabolic syndrome and insulin resistance models
- Neurodegeneration and neuroprotection research
- Circadian rhythm and chronobiology studies
As a substrate for both sirtuins and PARP enzymes, NAD+ sits at the intersection of energy metabolism, genomic stability, and longevity signalling — making it one of the most versatile tools in ageing biology research. Source for research: NAD+ 500mg Research Peptide. Further reading: What is NAD+?
SS-31: Mitochondrial Peptide for Cardiolipin and Energy Research
SS-31 (Elamipretide / MTP-131) is a synthetic aromatic-cationic tetrapeptide that selectively targets cardiolipin within the inner mitochondrial membrane. It is one of the most extensively studied mitochondrial peptides in both preclinical and clinical research, with a unique mechanism centred on stabilising mitochondrial cristae architecture and protecting the electron transport chain.
Key research areas include:
- Cardiolipin binding and mitochondrial cristae stabilisation
- Oxidative stress and ROS reduction models
- Mitochondrial bioenergetics and ATP synthesis
- Cardiac ischaemia-reperfusion injury models
- Heart failure and cardiomyopathy research
- Skeletal muscle ageing and sarcopenia studies
- Neurodegenerative disease models
- Age-related mitochondrial decline
SS-31 is notable for having progressed into human clinical trials as Elamipretide — making it one of the few mitochondrial peptides to reach this stage. Phase 2 trials have investigated its potential in heart failure with reduced ejection fraction (HFrEF) and Barth syndrome. Source for research: SS-31 10mg Research Peptide. Further reading: What is SS-31?
MOTS-C: Mitochondrial-Derived Longevity Peptide and AMPK Research
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a 16-amino acid mitochondrial-derived peptide (MDP) with a genuinely unusual origin — it is encoded not in the nuclear genome like most peptides, but within the mitochondrial genome itself. First characterised in 2015, it has attracted significant interest in metabolic biology and longevity research for its role as a retrograde mitochondrial signal.
Key research areas include:
- AMPK pathway activation and metabolic regulation
- Glucose homeostasis and insulin sensitivity models
- Mitochondrial-nuclear retrograde signalling
- Mitochondrial biogenesis and energy metabolism
- Age-related metabolic decline research
- Skeletal muscle biology and exercise physiology models
- Antioxidant defence and oxidative stress models
MOTS-c’s ability to translocate to the nucleus under metabolic stress — where it regulates gene expression related to glucose metabolism and antioxidant defence — makes it a compound of particular interest to researchers studying mitochondrial-nuclear communication. Source for research: MOTS-C 10mg Research Peptide. Further reading: What is MOTS-C?
How These Longevity Peptides Relate to Each Other
NAD+, SS-31, and MOTS-c each target distinct aspects of mitochondrial and metabolic biology, but their research areas frequently overlap:
- NAD+ — primarily studied as a coenzyme substrate for sirtuin and PARP pathways; central to energy metabolism and DNA repair
- SS-31 — primarily studied for its direct interaction with the inner mitochondrial membrane via cardiolipin; protects electron transport chain function and reduces ROS
- MOTS-c — primarily studied as a mitochondrial-derived signalling peptide; activates AMPK and influences whole-body metabolic homeostasis
Researchers in longevity biology often study these compounds in parallel, as they address complementary aspects of mitochondrial health — from energy substrate availability (NAD+) to membrane integrity (SS-31) to systemic metabolic signalling (MOTS-c).
Sourcing Longevity and Mitochondrial Peptides in the UK
All longevity and mitochondrial peptides supplied by Precision Chain Peptides are manufactured to ≥99% purity, HPLC-verified, and supplied with a batch-specific Certificate of Analysis. All compounds are dispatched from the UK and are supplied strictly for in-vitro and laboratory research use only.
Browse the full range: Research Peptide Range | NAD+ 500mg | SS-31 10mg | MOTS-C 10mg
Research Use Only
All compounds supplied by Precision Chain Peptides are strictly for in-vitro and laboratory research use only. They are not intended for human or animal consumption, personal use, or self-administration.
0 comments